首页> 外文OA文献 >The results of the international clinical study VICTORY: efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide (Valsacor® H) in routine clinical practice in patients with grade 1 and grade 2 hypertension

【2h】

The results of the international clinical study VICTORY: efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide (Valsacor® H) in routine clinical practice in patients with grade 1 and grade 2 hypertension

机译：国际临床研究胜利的结果：缬沙坦（Valsacor®）的抗高血压单疗法的疗效和安全性及其与氢氯噻嗪（Valsacor®H）的固定组合在1级和2级高血压患者的常规临床实践中

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
I E Chazova; T V Martynyuk; R Accetto; Yu Sirenko; J Vincelj; Jr JWidimsky; B Barbič-Žagar; M V Arhipov; Yu I Grinshtein; O D Ostroumova; A S Galjavich; O P Rotar; L A Haisheva; S V Nedogoda;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-grou [J] . Lacourciere Y, Poirier L, Hebert D, Clinical therapeutics . 2005,第7期

机译：两种缬沙坦和氢氯噻嗪固定剂量组合与缬沙坦单药治疗对2或3期收缩期高血压患者的降压功效和耐受性：8周，随机，双盲，平行
2. Comparison of the Efficacy and Safety Profiles of Two Fixed-Dose Combinations of Antihypertensive Agents, Amlodipine/Benazepril Versus Valsartan/Hydrochlorothiazide, in Patients With Type 2 Diabetes Mellitus and Hypertension: A 16-Week, Multicenter, Randomized, Double-Blind, Noninferiority Study [J] . LeeI.-T., HungY.-J., ChenJ.-F., Clinical therapeutics . 2012,第8期

机译：两种固定剂量抗高血压药氨氯地平/贝那普利与缬沙坦/氢氯噻嗪对2型糖尿病和高血压患者的疗效和安全性比较：一项为期16周的多中心随机双盲非劣效性研究
3. Comparison of the efficacy and safety of single-pill fixed-dose combinations of losartan/hydrochlorothiazide and valsartan/hydrochlorothiazide in patients with hypertension (SALT-VAT study) [J] . ShigaY., MiuraS.-I., MoriiJ., Internal medicine. . 2011,第21期

机译：氯沙坦/氢氯噻嗪和缬沙坦/氢氯噻嗪单药固定剂量联合治疗高血压患者的疗效和安全性比较（SALT-VAT研究）
4. Clinical Practice Guidelines Consistency for Patients with Multimorbidity: a Case-Study in the Management of Type 2 Diabetes and Hypertension [C] . Alexre GALOPIN, Jacques BOUAUD, Suzanne PEREIRA, Medical Informatics in Europe Conference. . 2015

机译：多药物患者的临床实践指导方针：2型糖尿病和高血压管理的案例研究
5. A multicenter randomized and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy [O] . Youngkeun Ahn, Yongcheol Kim, Kiyuk Chang, -1

机译：一项多中心随机双盲IV期临床试验比较了氨氯地平乳清酸/缬沙坦5 /160μmg与缬沙坦/氢氯噻嗪160 /12.5μmg固定剂量联合用药在不受缬沙坦160控制的原发性高血压患者中的疗效和安全性毫克单药
6. Antihypertensive Efficacy and Safety of Fixed-Dose Combination Therapy with Losartan plus Hydrochlorothiazide in Japanese Patients with Essential Hypertension [O] . Takao SARUTA, Toshio OGIHARA, Hiroaki MATSUOKA, 2007

机译：氯沙坦加上氯沙坦盐酸乳酸盐的抗高血压疗效和安全性，在日本必需高血压患者中

The results of the international clinical study VICTORY: efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide (Valsacor® H) in routine clinical practice in patients with grade 1 and grade 2 hypertension

著录项

引文网络

相似文献

相关主题

期刊订阅